PRINCYV
Brand Name: PRINCYV
Manufacturer: Dr. Reddy’s Laboratories
Composition: Palbociclib (125 mg)
Product Description
Medical Info
Princyv, manufactured by Dr. Reddy’s, is a targeted prescription oncology medication containing 125 mg of Palbociclib. It is classified as a CDK4/6 inhibitor, designed to treat HR-positive, HER2-negative advanced or metastatic breast cancer. By blocking specific proteins (cyclin-dependent kinases 4 and 6), Princyv slows the division and growth of cancer cells. It is typically used in combination with an aromatase inhibitor as initial endocrine-based therapy in postmenopausal women, or with fulvestrant in women whose disease has progressed after endocrine therapy. Each bottle contains 21 capsules, and treatment should always be monitored by a qualified healthcare professional.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
